Bloodstream Infections and Outcomes Following Allogeneic Hematopoietic Cell Transplantation: A Single-Center Study
Abel Santos Carreira(University Health Network), Jonas Mattsson(University Health Network), Jeffrey H. Lipton(Princess Margaret Cancer Centre), María Queralt Salas(Canary Institute of Cancer Research), Rajat Kumar(University Health Network), Armin Gerbitz(University Health Network), Igor Novitzky‐Basso(University Health Network), Arjun Law(University of Toronto), Ivan Pašić(University Health Network), Auro Viswabandya(Princess Margaret Cancer Centre), Fotios V. Michelis(Princess Margaret Cancer Centre), Shahid Husain(University Health Network), Dennis Kim(Princess Margaret Cancer Centre), Wilson Lam(Princess Margaret Cancer Centre), Mats Remberger(Uppsala University Hospital)
Cited by 37
Related Papers
BCR-ABL1 Compound Mutations Combining Key Kinase Domain Positions Confer Clinical Resistance to Ponatinib in Ph Chromosome-Positive Leukemia
|Cancer Cell|2014|366
Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinib
|Leukemia|2008|354
Assessment of Cytomegalovirus-Specific Cell-Mediated Immunity for the Prediction of Cytomegalovirus Disease in High-Risk Solid-Organ Transplant Recipients: A Multicenter Cohort Study
|Clinical Infectious Diseases|2012|299